A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HIV-1 Resistance, Proviral DNA (RTI, PI, Integrase Inhibitors) : 94807
Test CodeHIVPRO or 94807
Alias/See Also
Archived DNA, Cell-associated Viral DNA, Undetected viral load, Resistance Analysis, Archived resistance
CPT Codes
87900, 87901, 87906
Instructions
Lavender (EDTA) tube.
Transport Container
Submit 2 mL whole blood in EDTA (lavender-top) tube. (Min: 0.6 mL)
Transport Temperature
Refrigerated.
Specimen Stability
Room temperature: 7 days; Refrigerated: 7 days; Frozen: 28 days
Methodology
Polymerase Chain Reaction (PCR), Next Generation (ultra-deep) Sequencing
Setup Schedule
Tuesday & Saturday
Report Available
4-5 days (From receipt at performing laboratory)
Limitations
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range
See Laboratory Report.
Clinical Significance
This test utilizes PCR and next generation (ultra-deep) sequencing of proviral DNA to detect drug resistance mutations in the HIV-1 protease, reverse transcriptase and integrase genes. This information will assist clinicians considering a modification of the treatment regimens for virologically suppressed patients or for patients with a low viral load for whom an RNA resistance test was not successful.
Performing Laboratory
Quest Diagnostics